Cargando…

Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader‐Willi syndrome

OBJECTIVE: Prader‐Willi syndrome (PWS) is the most frequently diagnosed genetic cause of early childhood obesity. Individuals with PWS typically progress through 7 different nutritional phases during their lifetime. The main objective of this study was to assess potential factors, particularly insul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kweh, Frederick A., Sulsona, Carlos R., Miller, Jennifer L., Driscoll, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399533/ https://www.ncbi.nlm.nih.gov/pubmed/37546289 http://dx.doi.org/10.1002/osp4.663

Ejemplares similares

Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome
por: Miller, Jennifer L., et al.
Publicado: (2015)

Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome
por: Polex-Wolf, Joseph, et al.
Publicado: (2018)

Hyperphagia and Obesity in Prader–Willi Syndrome: PCSK1 Deficiency and Beyond?
por: Ramos-Molina, Bruno, et al.
Publicado: (2018)

Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome
por: Cho, Sung Yoon, et al.
Publicado: (2022)

The Hyperphagia Questionnaire: Insights From a Multicentric Validation Study in Individuals With Prader Willi Syndrome
por: Licenziati, Maria Rosaria, et al.
Publicado: (2022)

Molecular Characterization of a Patient Presumed to Have Prader-Willi Syndrome
por: Falaleeva, Marina, et al.
Publicado: (2013)

Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader–Willi syndrome
por: Davies, Jennifer R., et al.
Publicado: (2015)

Prader–Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment
por: Erhardt, Éva, et al.
Publicado: (2022)

Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
por: Kayadjanian, Nathalie, et al.
Publicado: (2021)

Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome
por: Matesevac, Lisa, et al.
Publicado: (2023)

Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
por: Roof, Elizabeth, et al.
Publicado: (2023)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

Prader–Willi Syndrome and Weight Gain Control: From Prevention to Surgery—A Narrative Review
por: Calcaterra, Valeria, et al.
Publicado: (2023)

Dietary Management for Adolescents with Prader–Willi Syndrome
por: Miller, Jennifer L, et al.
Publicado: (2020)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

Three Siblings with Prader-Willi Syndrome: Brief Review of Sleep and Prader-Willi Syndrome
por: Bingeliene, Arina, et al.
Publicado: (2015)

Topline Results of the CARE-PWS Phase 3 Study: Intranasal Carbetocin Improves Hyperphagia and Anxiety and Distress Symptoms in Prader-Willi Syndrome (PWS)
por: Ryman, Davis, et al.
Publicado: (2021)

Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome
por: Cheon, Chong Kun
Publicado: (2016)

Epigenetics in Prader-Willi Syndrome
por: Mendiola, Aron Judd P., et al.
Publicado: (2021)

Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the Global Prader-Willi Syndrome Registry
por: Bohonowych, Jessica E., et al.
Publicado: (2021)

Early Diagnosis in Prader–Willi Syndrome Reduces Obesity and Associated Co-Morbidities
por: Kimonis, Virginia E., et al.
Publicado: (2019)

Thrombosis Risk History and D-dimer Levels in Asymptomatic Individuals with Prader–Willi Syndrome
por: Matesevac, Lisa, et al.
Publicado: (2022)

The High Direct Medical Costs of Prader-Willi Syndrome
por: Shoffstall, Andrew J., et al.
Publicado: (2016)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
por: Diene, Gwenaëlle, et al.
Publicado: (2022)

Prader-Willi Syndrome: Clinical Aspects
por: Elena, Grechi, et al.
Publicado: (2012)

Hyperprolactinemia in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

Sleep Consequences of Prader-Willi Syndrome
por: Itani, Reem, et al.
Publicado: (2023)

Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey
por: Butler, Merlin G., et al.
Publicado: (2016)

Experiencing illness as a crisis by the caregivers of individuals with Prader-Willi Syndrome
por: Kowal, Katarzyna, et al.
Publicado: (2022)

The transition from pediatric to adult care in individuals with Prader-Willi syndrome
por: Poitou, Christine, et al.
Publicado: (2022)

Progress in Brain Magnetic Resonance Imaging of Individuals with Prader–Willi Syndrome
por: Huang, Zhongxin, et al.
Publicado: (2023)

Nutritional intakes in children with Prader–Willi syndrome and non-congenital obesity
por: Rubin, Daniela A., et al.
Publicado: (2015)

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update
por: Butler, Merlin G., et al.
Publicado: (2019)

Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader-Willi syndrome and in Prader-Willi syndrome associated psychosis
por: Heseding, Hannah M., et al.
Publicado: (2022)

Blunted Vagal Cocaine- and Amphetamine-Regulated Transcript Promotes Hyperphagia and Weight Gain
por: Lee, Shin J., et al.
Publicado: (2020)

The Global Prader–Willi Syndrome Registry: Development, Launch, and Early Demographics
por: Bohonowych, Jessica, et al.
Publicado: (2019)

Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome
por: Höybye, Charlotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g1r5c0pb1fc9nefnomq7ataifs